Peer-reviewed article
Female Immunisation During Various Age Periods
Nina V. Zarochentseva, Igor I. Baranov, Mikhail P. Kostinov, Yu.N. Bashankaeva ·
Summary
Written by AI, not yet AICS's view · claude-haiku-4-5-20251001This review examines the importance of vaccinating females across different life stages, from childhood through adulthood and pregnancy. The document argues that full immunisation of girls and women protects them against infections and provides protection to their future children through maternal antibodies passed during pregnancy and breastfeeding. The review concludes that vaccination is safe and effective for pregnant women, breastfeeding mothers, and their infants, and that lower vaccination rates lead to disease outbreaks and poor health outcomes.
Key points
- Maternal immunisation provides transplacental antibodies that protect newborns and reduce infection transmission risk in early years
- High IgG levels from vaccinated mothers can pass through the placenta to the baby, activating passive immunity
- Inactivated and live vaccines are safe for breastfeeding women and their infants in the postpartum period
- Lower vaccination rates result in controlled infection outbreaks, incapacity, fatal cases, and increased burden on healthcare systems
- Female immunisation is essential throughout a woman's life to prevent infections and protect both mother and child
Limitations
This is a review paper that does not present original empirical data or a systematic review methodology. It does not provide specific data on vaccination coverage rates, types of diseases prevented, or quantified health outcomes in different populations.
Abstract
Objective of the Review: To justify the need in female immunisation during various age periods. Key Points. Full-scale immunisation of girls and young women ensures their protection against infections, later — protection of their foetus and newborns who have transplacental antibodies from their mothers. Full-scale female immunisation is essential because of the severity of infectious processes in pregnant women and unfavourable impact for the foetus and newborn. There are more and more evidences that maternal immunisation is safe, well-tolerated and efficient both for pregnant women and their newborns. High IgG levels can pass through placenta to the baby, reducing the risk of transmission of infection to the baby and activating passive immunity in early years. In postpartum period, inactivated and/or live vaccines are safe both for breastfeeding women and their infants. Conclusion. Vaccination is an efficient and safe way to prevent infections and their consequences throughout the life of a woman and her child. Lower vaccination rates cause controlled infection outbreaks, incapacitation and fatal cases, poor epidemical situation, and higher burden for the healthcare system. Keywords: immunisation, vaccination, pregnancy.